Sunday November 22 2009 | Biotechnology feed | All feeds
April to June 2007 Syngene Appoints New US Distributors and Sales Manager To Provide Superior Service and Support for US Customers ReaX™ Custom Bead Service used for a novel field-based DNA security marking Merck Deploys ArisGlobal’s Register™ Globally Cellexus Biosystems plc appoints IUL as its exclusive distributor in Austria, Benelux Germany, the Netherlands and Switzerland OXFORD GENE TECHNOLOGY GRANTS MICROARRAY LICENSE TO OCEAN RIDGE BIOSCIENCES FOR MICROARRAY SERVICES NiKem Research Srl Enters Into Research Service Agreement with InterMune, Inc. Genetic Tests for Thrombotic Disease Could Save Lives and Reduce Healthcare Costs Celogos Awarded ‘Médaille de la Ville’ for Contribution to Paris Economy LifeCycle Pharma to Initiate Phase II Clinical Trial of LCP-Tacro for Organ Transplantation LifeCycle Pharma Forms Scientific Advisory Board in Solid Organ Transplantation Amsterdam Molecular Therapeutics announces pricing of Initial Public Offering (IPO) on Euronext Amsterdam Cellexus Biosystems plc appoints Appropriate Technical Resources Inc. as US Distributor BioInvent implements a directed new share issue worth SEK 125 million and summons to an extraordinary shareholders' meeting SANTARIS Hanne Damgaard Jensen appointed as SVP Product Development at Santaris Pharma Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics GATC strengthens management team with appointment of Dr Marcus Benz as Chief Operating Officer INTEGRAGEN BECOMES FIRST CERTIFIED FRENCH SERVICE PROVIDER FOR ILLUMINA GOLDENGATE AND INFINIUM GENOTYPING Pronota strengthens commercial team with appointment of Business Development Directo New flu vaccine from PepTcell could provide immunity against all strains of influenza virus Agilent Technologies Adds Strength to Its Life Science Business with Acquisition of Stratagene TransPharma Medical Receives Second Milestone Payment from Teva Pharmaceutical Industries World Leading Cardiologists Join BSP's Scientific Advisory Board OXFORD GENE TECHNOLOGY GRANTS MICROARRAY LICENSE TO AUSHON BIOSYSTEMS Johnson & Johnson Selects ArisGlobal as its Global Pharmacovigilance and Safety Partner IDBS announces the release of E-WorkBook Suite 7.0 New Feature in 2D Protein Gel Analysis Software Improves Confidence and Productivity in Proteomics Research Clinical Data's Cogenics Division Launches Services on Roche 454 GS FLX Forbion Announces Successful Exit from Alantos Pharmaceuticals Amsterdam Molecular Therapeutics announces launch of Initial Public Offering (IPO) on Euronext Amsterdam Faust Pharmaceuticals Present Phase IIa Results for Parkinson's Disease Santaris Pharma presents positive clinical data on SPC2996 in Chronic Lymphocytic Leukaemia Research centre Jülich and ibidi launch in vivo-like cell cultivation on soft surfaces Protagen expands Supervisory Board to support the development and commercialisation of its protein biochips Thermo Fisher Scientific Introduces Revolutionary Device for Effective, Long-Lasting Prevention of Waterborne Contamination Thrombotargets Corp. and Chemotargets to collaborate on identification of novel hits related with cardiovascular diseases Thrombotargets Corp. Announces the Membership of Its New Scientific Advisory Board AUSTRIANOVA completes first closing of 35 M EURO Series B financing Diatos announces positive Phase I results for DTS-201 Doxorubicin prodrug program Cytheris to start two phase I/IIa clinical trials of CYT107, its new recombinant Interleukin-7, in Hepatitis C and oncology BPI’s International Impact Honored by PRECARN deltaDOT Ltd and Integrated Technologies receive £465k Grant from South East England Development Agency to develop Osprey, a decisive new tool in drug discovery AMT Receives Orphan Drug Designation from FDA for AMT 011 for the Treatment of Lipoprotein Lipase Deficiency OXFORD BIOMEDICA AND SANOFI-AVENTIS REPORT NEW TROVAX PHASE II TRIAL RESULTS IN RENAL CANCER BRANE DISCOVERY ACQUIRES ORL-1 PROGRAM FROM NIKEM RESEARCH Isogenica Enters into Research and License Agreement with Wyeth Thermo Fisher Scientific Launches New Stackable Shaker Cobra awarded DTI Grant to develop Cobra's oral vaccine delivery platform AMT Presents Positive Results of Phase I/II Study with Lead Product at Annual Meeting of American Society of Gene Therapy LifeCycle Pharma Announces Positive Phase I Clinical Results for its Transplantation Product Candidate, LCP-Tacro Free pharmaceutical industry innovation and patent expiration metrics for media outlets InferMed appoints new CEO Thermo Fisher Scientific Announces New General Purpose Centrifuge System Navigate the Fluorescent Minefield with a Free Poster on the "Spectra of Fluorescent Dyes" from Olympus Mr. Gilles Brisson to join Cytomics Systems’ Supervisory Board BioInvent updates project portfolio Pronota strengthens board with appointment of Chairman Dr Flemming Ørnskov appointed Chairman of Santaris Pharma Board Q Chip launches the ReaXT 'Lab-in-a-Bead' technology - taking the mystery out of PCR Arrayjet and BioMicro Systems partner in the USA Arrayjet Launches Peerless Benchtop Inkjet Microarray Spotter for R&D Market Amsterdam Molecular Therapeutics announces intention to launch an Initial Public Offering (IPO) on Euronext Amsterdam Scil Technology GmbH obtained Competent Authority Approval for Phase II Periodontitis Study MIP Technologies and Supelco Launch a New Selective SPE Product for Analysis of Tobacco-Specific Nitrosamines TTP LABTECH'S MOSQUITO PROVIDES A UNIQUE APPROACH TO HANGING DROP AUTOMATION PHASE II RESULTS FOR OXFORD BIOMEDICA'S HI-8 MEL IN MELANOMA TO BE PRESENTED AT AAI MEETING Intelligent Design Makes Automated Chemistry Affordable Protagen and ZAP partner with Kangdi Antibody Biotech and Bejing Proteome Research Centre to develop antibodies Cellexus Biosystems plc launches the CellMaker Lite2TM – the latest generation of its novel disposable bioreactor Agilent Technologies’ Mass Spectrometer with HPLC Chip Proves Winning Combo for New Blue Stream Laboratories Facility Agilent Technologies Launches New Inductively Coupled Mass Spectrometer Delivering Higher Productivity, More Accurate Results Agilent Technologies Receives the 2006 Frost & Sullivan Growth Strategy Leadership Award Lectus Therapeutics wins ERBI's Innovation in Drug Discovery and Development Award LifeCycle Pharma Receives US Patent for its MeltDose® Technology Studies present compelling data on the p16(INK4a) biomarker at the 16th International Congress of Cytology New High Resolution Image Analyser - Generates Excellent Results with Qdot Labelled Western Blots Nautilus Biotech receives FDA approval for Phase 1 clinical trial in the USA for oral BelerofonR, its long-lasting, Interferon-alpha drug Olympus Introduces FV1000 Multi-Laser Combiner System - Revolutionary multi-laser source! New Species Named After Thermo Fisher Scientific: Fissuroderes thermoi Targeted Genetics initiates phase I trial for childhood blindness Angioblast cleared to trial stem-cell therapy for heart attack patients Trexima has demonstrated consistent pain-free results across multiple migraine attacks Array BioPharma initiates clinical trials of cancer drug Additional indication for Pfizer's Fragmin Dr Reddy's: Indian generic Rituxan launch flashes warning to biologics industry Magnisense Appoints Business Developer for US Diagnostics Market IDBS announces strategic partnership to improve presence and reach of Professional Services in German-speaking regions Forbion Capital Partners adds top tier investors to its investor base Astech Projects Launch the Astech Automation Challenge ILLUMINA INFINIUM BEADCHIPS SELECTED BY GERMANY'S NATIONAL GENOME RESEARCH NETWORK TO SUPPORT ONE OF THE WORLD'S LARGEST GENETIC DISEASE STUDIES TO DATE Thrombotargets Corp. and Specs achieve milestone in their Drug Discovery collaboration and announce the beginning of a new Anticoagulant program. Thrombotargets inaugurates new facilities at the National Biotechnology Centre (CNB) in Madrid, Spain Thrombotargets Corporation relocates to Research Triangle Park in North Carolina Thrombotargets Corporation and Instituto Biomar to collaborate on identification and optimization of new drug candidates Thrombotargets Corporation Receives Orphan Drug Designation from the U.S. Food and Drug Administration for its Procoagulant Agent, TT-103MH, in the Treatment of Bleeding Episodes in Hemophiliacs Midatech Group announces the opening of cGMP standard facility for the production of nanoparticles BAC ANNOUNCES COLLABORATION WITH SANOFI PASTEUR FOR VACCINE PURIFICATION LifeCycle Pharma signs exclusive license agreement with Sciele Pharma to market a new formulation of fenofibrate in 120mg and 40mg dosage strengths GATC Biotech demonstrates new DNA sequencing capability and sequences 9 bacterial genomes in April ProtAffin AG secures Series A financing Growing medical jobs careersite partners with GeneEd to offer online CME and CE courses BioAlliance Pharma presents at BIO 2007 Amsterdam Molecular Therapeutics BV to present preclinical proof-of-concept data on its gene therapy AMT-020 to treat acute intermittent MIP Technologies and Supelco launch a new selective SPE product for the simultaneous extraction of beta agonists and antagonists BioAlliance Pharma Announces Consolidated Revenues for Q1 2007 Nautilus Biotech closes €8.4 million ($11.3 million) investment funding Lab21 announces appointment of new Chief Financial Officer Biota announces A$16m quarterly royalties from Relenza antiviral Protagen launches GMP protein analysis services BioAlliance Pharma Announces Participation in Paris SmallCap Event April 26-27 APPLICATIONS OPEN FOR BURSARIES FOR BSR 2007 BRANE DISCOVERY LAUNCHED AS SPIN OUT OF R&D PROGRAMMES FROM NIKEM RESEARCH Bridgehead International wins The Queen’s Award for Enterprise Titian's Mosaic sample management software rapidly becoming industry standard The latest in screening data management with ActivityBase XE v7.0 LANI completes Phase I in Japan and to commence Phase I in UK Gene Bridges and BASF sign collaboration agreement Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research Agilent Technologies First Comprehensive Microarray System for Expression Profiling of Human miRNAs Agilent Technologies Announces Belfast Winner of its Largest Ever European Promotional Prize New CellReporter live cell based assay system from Genetix Thermo Fisher Scientific Introduces Four Advanced Enhancements for its High Content Screening Platform CAMBRIDGE ANTIBODY TECHNOLOGY AND PHILOCHEM ANNOUNCE TECHNOLOGY EVALUATION AGREEMENT LibraGen Launches its First Family of Active Products Obtained by Enzymatic Transformation of Natural Substances BioInvent Interim Report 1 January–31 March 2007 Hybrigenics' Inecalcitol Shows High Level of Tolerance Thermo Fisher Scientific Introduces New -86°C Freezers EU Commission issues a major communication on biotechnology - the Biotech industry responds Novosom AG acquires exclusive option for CD40-targeted antisense inhibitors from Isis Pharmaceuticals TTP LABTECH EXTENDS GLOBAL REACH Success of mosquito® and Acumen® eX3 leads new distribution agreements for Japan, India and Australia New Zealand Dymension 2D Gel Analysis Software installed at Specialist University Biacore to host DiPIA 2007 conference in Phoenix, Arizona May 6-9, Pointe Hilton Squaw Peak Resort More Rapid Than Expected Type 2 Diabetes Incidence Will Drive Diagnostics and Therapeutics Market to $33 Billion by 2016 Affimed Closes € 25 million (US $ 32 million) Series B financing Cytheris Names CFO and CMO as Company Boosts Clinical Development Program in Europe and the US BPI Announces First Sales of Next-Generation TISSUEscope ™ BAC AND GE HEALTHCARE ANNOUNCE FVIII PURIFICATION MEDIA COLLABORATION Nautilus Biotech begins Phase I clinical trial in the USA for subcutaneous Belerofon®, its long-lasting, Interferon-alpha drug Bt maize crops delivering health, wealth and environmental benefits in Europe January to March 2008 Biotechnology News October to December 2007 Biotechnology News July to September 2007 April to June 2007 January to March 2007 BioNewsCast Press Release Service 2006 Archive - January 2006 ~ February 2006 ~ March 2006 ~ April 2006 ~ May 2006 ~ June 2006 ~ July 2006 ~ August 2006 ~ September 2006 ~ October 2006 ~ November - December 2006 BioNewsCast Press Release Service 2005 Archive - December 2005 ~ November 2005 ~ October 2005 BioNewsCast Press Release Service 2004 Archive BioNewsCast Press Release Service 2003 Archive BioNewsCast Press Release Service 2002 Archive Site Map - new news site Site Map - old news site
April to June 2007
Syngene Appoints New US Distributors and Sales Manager To Provide Superior Service and Support for US Customers
ReaX™ Custom Bead Service used for a novel field-based DNA security marking
Merck Deploys ArisGlobal’s Register™ Globally
Cellexus Biosystems plc appoints IUL as its exclusive distributor in Austria, Benelux Germany, the Netherlands and Switzerland
OXFORD GENE TECHNOLOGY GRANTS MICROARRAY LICENSE TO OCEAN RIDGE BIOSCIENCES FOR MICROARRAY SERVICES
NiKem Research Srl Enters Into Research Service Agreement with InterMune, Inc.
Genetic Tests for Thrombotic Disease Could Save Lives and Reduce Healthcare Costs
Celogos Awarded ‘Médaille de la Ville’ for Contribution to Paris Economy
LifeCycle Pharma to Initiate Phase II Clinical Trial of LCP-Tacro for Organ Transplantation
LifeCycle Pharma Forms Scientific Advisory Board in Solid Organ Transplantation
Amsterdam Molecular Therapeutics announces pricing of Initial Public Offering (IPO) on Euronext Amsterdam
Cellexus Biosystems plc appoints Appropriate Technical Resources Inc. as US Distributor
BioInvent implements a directed new share issue worth SEK 125 million and summons to an extraordinary shareholders' meeting
SANTARIS Hanne Damgaard Jensen appointed as SVP Product Development at Santaris Pharma
Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
GATC strengthens management team with appointment of Dr Marcus Benz as Chief Operating Officer
INTEGRAGEN BECOMES FIRST CERTIFIED FRENCH SERVICE PROVIDER FOR ILLUMINA GOLDENGATE AND INFINIUM GENOTYPING
Pronota strengthens commercial team with appointment of Business Development Directo
New flu vaccine from PepTcell could provide immunity against all strains of influenza virus
Agilent Technologies Adds Strength to Its Life Science Business with Acquisition of Stratagene
TransPharma Medical Receives Second Milestone Payment from Teva Pharmaceutical Industries
World Leading Cardiologists Join BSP's Scientific Advisory Board
OXFORD GENE TECHNOLOGY GRANTS MICROARRAY LICENSE TO AUSHON BIOSYSTEMS
Johnson & Johnson Selects ArisGlobal as its Global Pharmacovigilance and Safety Partner
IDBS announces the release of E-WorkBook Suite 7.0
New Feature in 2D Protein Gel Analysis Software Improves Confidence and Productivity in Proteomics Research
Clinical Data's Cogenics Division Launches Services on Roche 454 GS FLX
Forbion Announces Successful Exit from Alantos Pharmaceuticals
Amsterdam Molecular Therapeutics announces launch of Initial Public Offering (IPO) on Euronext Amsterdam
Faust Pharmaceuticals Present Phase IIa Results for Parkinson's Disease
Santaris Pharma presents positive clinical data on SPC2996 in Chronic Lymphocytic Leukaemia
Research centre Jülich and ibidi launch in vivo-like cell cultivation on soft surfaces
Protagen expands Supervisory Board to support the development and commercialisation of its protein biochips
Thermo Fisher Scientific Introduces Revolutionary Device for Effective, Long-Lasting Prevention of Waterborne Contamination
Thrombotargets Corp. and Chemotargets to collaborate on identification of novel hits related with cardiovascular diseases
Thrombotargets Corp. Announces the Membership of Its New Scientific Advisory Board
AUSTRIANOVA completes first closing of 35 M EURO Series B financing
Diatos announces positive Phase I results for DTS-201 Doxorubicin prodrug program
Cytheris to start two phase I/IIa clinical trials of CYT107, its new recombinant Interleukin-7, in Hepatitis C and oncology
BPI’s International Impact Honored by PRECARN
deltaDOT Ltd and Integrated Technologies receive £465k Grant from South East England Development Agency to develop Osprey, a decisive new tool in drug discovery
AMT Receives Orphan Drug Designation from FDA for AMT 011 for the Treatment of Lipoprotein Lipase Deficiency
OXFORD BIOMEDICA AND SANOFI-AVENTIS REPORT NEW TROVAX PHASE II TRIAL RESULTS IN RENAL CANCER
BRANE DISCOVERY ACQUIRES ORL-1 PROGRAM FROM NIKEM RESEARCH
Isogenica Enters into Research and License Agreement with Wyeth
Thermo Fisher Scientific Launches New Stackable Shaker
Cobra awarded DTI Grant to develop Cobra's oral vaccine delivery platform
AMT Presents Positive Results of Phase I/II Study with Lead Product at Annual Meeting of American Society of Gene Therapy
LifeCycle Pharma Announces Positive Phase I Clinical Results for its Transplantation Product Candidate, LCP-Tacro
Free pharmaceutical industry innovation and patent expiration metrics for media outlets InferMed appoints new CEO
Thermo Fisher Scientific Announces New General Purpose Centrifuge System
Navigate the Fluorescent Minefield with a Free Poster on the "Spectra of Fluorescent Dyes" from Olympus
Mr. Gilles Brisson to join Cytomics Systems’ Supervisory Board
BioInvent updates project portfolio
Pronota strengthens board with appointment of Chairman
Dr Flemming Ørnskov appointed Chairman of Santaris Pharma Board
Q Chip launches the ReaXT 'Lab-in-a-Bead' technology - taking the mystery out of PCR
Arrayjet and BioMicro Systems partner in the USA
Arrayjet Launches Peerless Benchtop Inkjet Microarray Spotter for R&D Market
Amsterdam Molecular Therapeutics announces intention to launch an Initial Public Offering (IPO) on Euronext Amsterdam
Scil Technology GmbH obtained Competent Authority Approval for Phase II Periodontitis Study
MIP Technologies and Supelco Launch a New Selective SPE Product for Analysis of Tobacco-Specific Nitrosamines
TTP LABTECH'S MOSQUITO PROVIDES A UNIQUE APPROACH TO HANGING DROP AUTOMATION
PHASE II RESULTS FOR OXFORD BIOMEDICA'S HI-8 MEL IN MELANOMA TO BE PRESENTED AT AAI MEETING
Intelligent Design Makes Automated Chemistry Affordable
Protagen and ZAP partner with Kangdi Antibody Biotech and Bejing Proteome Research Centre to develop antibodies
Cellexus Biosystems plc launches the CellMaker Lite2TM – the latest generation of its novel disposable bioreactor
Agilent Technologies’ Mass Spectrometer with HPLC Chip Proves Winning Combo for New Blue Stream Laboratories Facility
Agilent Technologies Launches New Inductively Coupled Mass Spectrometer Delivering Higher Productivity, More Accurate Results
Agilent Technologies Receives the 2006 Frost & Sullivan Growth Strategy Leadership Award
Lectus Therapeutics wins ERBI's Innovation in Drug Discovery and Development Award
LifeCycle Pharma Receives US Patent for its MeltDose® Technology
Studies present compelling data on the p16(INK4a) biomarker at the 16th International Congress of Cytology
New High Resolution Image Analyser - Generates Excellent Results with Qdot Labelled Western Blots
Nautilus Biotech receives FDA approval for Phase 1 clinical trial in the USA for oral BelerofonR, its long-lasting, Interferon-alpha drug
Olympus Introduces FV1000 Multi-Laser Combiner System - Revolutionary multi-laser source!
New Species Named After Thermo Fisher Scientific: Fissuroderes thermoi
Targeted Genetics initiates phase I trial for childhood blindness
Angioblast cleared to trial stem-cell therapy for heart attack patients
Trexima has demonstrated consistent pain-free results across multiple migraine attacks
Array BioPharma initiates clinical trials of cancer drug
Additional indication for Pfizer's Fragmin
Dr Reddy's: Indian generic Rituxan launch flashes warning to biologics industry
Magnisense Appoints Business Developer for US Diagnostics Market
IDBS announces strategic partnership to improve presence and reach of Professional Services in German-speaking regions
Forbion Capital Partners adds top tier investors to its investor base
Astech Projects Launch the Astech Automation Challenge
ILLUMINA INFINIUM BEADCHIPS SELECTED BY GERMANY'S NATIONAL GENOME RESEARCH NETWORK TO SUPPORT ONE OF THE WORLD'S LARGEST GENETIC DISEASE STUDIES TO DATE
Thrombotargets Corp. and Specs achieve milestone in their Drug Discovery collaboration and announce the beginning of a new Anticoagulant program.
Thrombotargets inaugurates new facilities at the National Biotechnology Centre (CNB) in Madrid, Spain
Thrombotargets Corporation relocates to Research Triangle Park in North Carolina
Thrombotargets Corporation and Instituto Biomar to collaborate on identification and optimization of new drug candidates
Thrombotargets Corporation Receives Orphan Drug Designation from the U.S. Food and Drug Administration for its Procoagulant Agent, TT-103MH, in the Treatment of Bleeding Episodes in Hemophiliacs
Midatech Group announces the opening of cGMP standard facility for the production of nanoparticles
BAC ANNOUNCES COLLABORATION WITH SANOFI PASTEUR FOR VACCINE PURIFICATION
LifeCycle Pharma signs exclusive license agreement with Sciele Pharma to market a new formulation of fenofibrate in 120mg and 40mg dosage strengths
GATC Biotech demonstrates new DNA sequencing capability and sequences 9 bacterial genomes in April
ProtAffin AG secures Series A financing
Growing medical jobs careersite partners with GeneEd to offer online CME and CE courses
BioAlliance Pharma presents at BIO 2007
Amsterdam Molecular Therapeutics BV to present preclinical proof-of-concept data on its gene therapy AMT-020 to treat acute intermittent
MIP Technologies and Supelco launch a new selective SPE product for the simultaneous extraction of beta agonists and antagonists
BioAlliance Pharma Announces Consolidated Revenues for Q1 2007
Nautilus Biotech closes €8.4 million ($11.3 million) investment funding
Lab21 announces appointment of new Chief Financial Officer
Biota announces A$16m quarterly royalties from Relenza antiviral
Protagen launches GMP protein analysis services
BioAlliance Pharma Announces Participation in Paris SmallCap Event April 26-27
APPLICATIONS OPEN FOR BURSARIES FOR BSR 2007
BRANE DISCOVERY LAUNCHED AS SPIN OUT OF R&D PROGRAMMES FROM NIKEM RESEARCH
Bridgehead International wins The Queen’s Award for Enterprise
Titian's Mosaic sample management software rapidly becoming industry standard
The latest in screening data management with ActivityBase XE v7.0
LANI completes Phase I in Japan and to commence Phase I in UK
Gene Bridges and BASF sign collaboration agreement
Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research
Agilent Technologies First Comprehensive Microarray System for Expression Profiling of Human miRNAs
Agilent Technologies Announces Belfast Winner of its Largest Ever European Promotional Prize
New CellReporter live cell based assay system from Genetix
Thermo Fisher Scientific Introduces Four Advanced Enhancements for its High Content Screening Platform
CAMBRIDGE ANTIBODY TECHNOLOGY AND PHILOCHEM ANNOUNCE TECHNOLOGY EVALUATION AGREEMENT
LibraGen Launches its First Family of Active Products Obtained by Enzymatic Transformation of Natural Substances
BioInvent Interim Report 1 January–31 March 2007
Hybrigenics' Inecalcitol Shows High Level of Tolerance
Thermo Fisher Scientific Introduces New -86°C Freezers
EU Commission issues a major communication on biotechnology - the Biotech industry responds
Novosom AG acquires exclusive option for CD40-targeted antisense inhibitors from Isis Pharmaceuticals
TTP LABTECH EXTENDS GLOBAL REACH Success of mosquito® and Acumen® eX3 leads new distribution agreements for Japan, India and Australia New Zealand
Dymension 2D Gel Analysis Software installed at Specialist University
Biacore to host DiPIA 2007 conference in Phoenix, Arizona May 6-9, Pointe Hilton Squaw Peak Resort
More Rapid Than Expected Type 2 Diabetes Incidence Will Drive Diagnostics and Therapeutics Market to $33 Billion by 2016
Affimed Closes € 25 million (US $ 32 million) Series B financing Cytheris Names CFO and CMO as Company Boosts Clinical Development Program in Europe and the US
BPI Announces First Sales of Next-Generation TISSUEscope ™
BAC AND GE HEALTHCARE ANNOUNCE FVIII PURIFICATION MEDIA COLLABORATION
Nautilus Biotech begins Phase I clinical trial in the USA for subcutaneous Belerofon®, its long-lasting, Interferon-alpha drug
Bt maize crops delivering health, wealth and environmental benefits in Europe
January to March 2008 Biotechnology News
October to December 2007 Biotechnology News
July to September 2007
January to March 2007
BioNewsCast Press Release Service 2006 Archive - January 2006 ~ February 2006 ~ March 2006 ~ April 2006 ~ May 2006 ~ June 2006 ~ July 2006 ~ August 2006 ~ September 2006 ~ October 2006 ~ November - December 2006
BioNewsCast Press Release Service 2005 Archive - December 2005 ~ November 2005 ~ October 2005
BioNewsCast Press Release Service 2004 Archive
BioNewsCast Press Release Service 2003 Archive
BioNewsCast Press Release Service 2002 Archive
Site Map - new news site
Site Map - old news site
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright © 1997-2009 - BioPortfolio Limited.